Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
261 hedge funds and large institutions have $865M invested in Avanos Medical in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 55 increasing their positions, 100 reducing their positions, and 37 closing their positions.
28% more call options, than puts
Call options by funds: $465K | Put options by funds: $363K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 37
2% less funds holding
Funds holding: 265 → 261 (-4)
1.61% less ownership
Funds ownership: 95.63% → 94.02% (-1.6%)
13% less capital invested
Capital invested by funds: $997M → $865M (-$132M)
45% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 100
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brown Advisory
Baltimore,
Maryland
|
+$27M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.66M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$3.96M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$3.7M |
| 5 |
N
Numerai
San Francisco,
California
|
+$2.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$10.2M |
| 2 |
Morgan Stanley
New York
|
-$10M |
| 3 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$9.27M |
| 4 |
PIM
Paradice Investment Management
Denver,
Colorado
|
-$7.3M |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$4.48M |
AVNS Hedge Fund Activity: Q1 2024 in Review
261 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2024, worth a combined $865M — down 13% from $997M a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of AVNS and 36 opened new positions — a net loss of 1 holder — while 100 trimmed existing stakes and 55 added.
The largest buyer was Brown Advisory, opening a new position worth an estimated $27M. The largest seller was Goldman Sachs, cutting an estimated $10.2M.
- 261 institutional investors held Avanos Medical (AVNS) as of Q1 2024, down from 265 in Q4 2023.
- Funds reported $865M of Avanos Medical stock for Q1 2024, down 13% quarter-over-quarter.
- 36 funds opened new Avanos Medical positions in Q1 2024 and 37 closed out, a net change of -1 holder.
- The largest Avanos Medical buyer in Q1 2024 was Brown Advisory, an estimated $27M added.
- The largest Avanos Medical seller in Q1 2024 was Goldman Sachs, an estimated $10.2M sold.
Based on aggregated 13F filings for Q1 2024.